DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7x3q48/global_infectious) has announced the addition of the "Global Infectious Diseases Drug Pipeline Capsule - 2013" report to their offering.
The latest report Global Infectious Diseases Drug Pipeline Capsule - 2013' provides up-to-date information on key research and development activities in the global infectious diseases drug market. It covers active pipeline molecules under development in various stages of clinical trials, preclinical research, and drug discovery for Hepatitis, HIV, Influenza, Small Pox, Malaria, Tuberculosis, Tetanus, Herpes Simplex, and Human Papillomavirus.
This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating business opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company, mechanism of action, stage (phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and drug discovery), and geography (North America, Europe, and Asia).
Key Features of the Report:
- Infectious Diseases Drug Pipeline Insights
- Hepatitis Drug Pipeline Insights
- HIV Drug Pipeline Insights
- Influenza Drug Pipeline Insights
- Small Pox Drug Pipeline Insights
- Malaria Drug Pipeline Insights
- Tuberculosis Drug Pipeline Insights
- Tetanus Drug Pipeline Insights
- Herpes Simplex Drug Pipeline Insights
- Human Papillomavirus Drug Pipeline Insights
For more information visit http://www.researchandmarkets.com/research/7x3q48/global_infectious
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.